Cart
sales@molnova.com
YK-2-69
CAS No. 2619846-89-6
YK-2-69( —— )
Catalog No. M36287 CAS No. 2619846-89-6
YK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 686 | In Stock |
|
| 10MG | 938 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYK-2-69
-
NoteResearch use only, not for human use.
-
Brief DescriptionYK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
-
DescriptionYK-2-69 is a highly selective DYRK2 inhibitor with anti-prostate cancer effects.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorDYRK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2619846-89-6
-
Formula Weight506.6
-
Molecular FormulaC25H27FN8OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C1=CN=C(C=C1)NC=2N=CC(F)=C(N2)C=3C=CC=4N=C(SC4C3)N(C)C)N5CCN(CC)CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Balsalazide disodium...
Balsalazide is an anti-inflammatory compound used in the treatment of Inflammatory Bowel Disease.Balsalazide is a new 5-aminosalicylic acid (5-ASA) containing prodrug.
-
Ladiratuzumab
LadiratuzumAb (hLIV22) is a humanized monoclonal antibody targeting LIV-1/ZIP6.LadiratuzumAb is a naked antibody to SGN-LIV1A and is capable of synthesizing an antibody-activated molecule coupling (ADC), SGN-LIV1A.
-
Risuteganib hydrochl...
Risuteganib hydrochloride is an anti-integrin that downregulates oxidative stress and restores homeostasis, and targets three integrin receptors that are implicated in dry age-related macular degeneration (AMD) in order to restore homeostasis in the retina.
